Literature DB >> 25470722

Different health behaviours and clinical factors associated with bone mineral density and bone turnover in premenopausal women with and without type 1 diabetes.

Amber S Kujath1, Lauretta Quinn, Mary E Elliott, Tamara J LeCaire, Neil Binkley, Andrea R Molino, Kirstie K Danielson.   

Abstract

BACKGROUND: Women with type 1 diabetes (T1DM) have an elevated fracture risk. We therefore compared the associations of health behaviours and clinical factors with bone mineral density (BMD) and bone remodelling between premenopausal women with and without T1DM to inform potential interventions.
METHODS: Participants included women with T1DM (n = 89) from the Wisconsin Diabetes Registry Study and age-matched and race-matched controls without diabetes (n = 76). Peripheral (heel and forearm) and central (hip and spine) BMD, markers of bone resorption and formation, bone cell signalling, glycaemic control, and kidney function were assessed. Health behaviours and medical history were self-reported.
RESULTS: In controls, but not in women with T1DM, older age was associated with lower bone resorption (p ≤ 0.006) and formation (p = 0.0007). Body mass index was positively associated with heel and forearm BMD in both controls and T1DM women (all p < 0.0001), but with hip and spine BMD only in controls (p ≤ 0.005). Worse glycaemic control during the previous 10 years, greater alcohol intake, history of smoking, and lack of physical activity were associated with poorer bone outcomes only in women with T1DM (all p ≤ 0.002), whereas use of hormonal contraceptives was related to low bone formation in both women with and without T1DM (all p ≤ 0.006). Diabetes duration, insulin dose, residual C-peptide, and kidney function were not associated with bone in T1DM.
CONCLUSIONS: Age and body mass index may not predict bone health in T1DM women. However, modifiable behaviours such as optimizing glycaemic control, limiting substance and hormonal contraceptive use, and increasing physical activity may improve bone health in T1DM women.
Copyright © 2014 John Wiley & Sons, Ltd.

Entities:  

Keywords:  bone mineral density; bone turnover markers; glycaemic control; type 1 diabetes

Mesh:

Substances:

Year:  2015        PMID: 25470722      PMCID: PMC4406845          DOI: 10.1002/dmrr.2627

Source DB:  PubMed          Journal:  Diabetes Metab Res Rev        ISSN: 1520-7552            Impact factor:   4.876


  64 in total

1.  Bone mineral density, bone turnover, and osteoprotegerin in depressed women with and without borderline personality disorder.

Authors:  Kai G Kahl; Wiebke Greggersen; Sebastian Rudolf; Beate M Stoeckelhuber; Claudia U Bergmann-Koester; Leif Dibbelt; Ulrich Schweiger
Journal:  Psychosom Med       Date:  2006 Sep-Oct       Impact factor: 4.312

2.  Parathormone--25(OH)-vitamin D axis and bone status in children and adolescents with type 1 diabetes mellitus.

Authors:  Enas A Hamed; Nagla H Abu Faddan; Hebh A Adb Elhafeez; Douaa Sayed
Journal:  Pediatr Diabetes       Date:  2011-03-22       Impact factor: 4.866

3.  Circulating amounts of osteoprotegerin and RANK ligand: genetic influence and relationship with BMD assessed in female twins.

Authors:  Bo Abrahamsen; Jacob Vb Hjelmborg; Paul Kostenuik; Lis S Stilgren; Kirsten Kyvik; Stephen Adamu; Kim Brixen; Bente L Langdahl
Journal:  Bone       Date:  2005-04       Impact factor: 4.398

4.  Do all prepubertal years of diabetes duration contribute equally to diabetes complications?

Authors:  Kim C Donaghue; Jan M Fairchild; Maria E Craig; Albert K Chan; Stephen Hing; Lucy R Cutler; Neville J Howard; Martin Silink
Journal:  Diabetes Care       Date:  2003-04       Impact factor: 19.112

5.  Middle-aged premenopausal women with type 1 diabetes have lower bone mineral density and calcaneal quantitative ultrasound than nondiabetic women.

Authors:  Elsa S Strotmeyer; Jane A Cauley; Trevor J Orchard; Ann R Steenkiste; Janice S Dorman
Journal:  Diabetes Care       Date:  2006-02       Impact factor: 19.112

6.  Reproducibility and validity of a semiquantitative food frequency questionnaire.

Authors:  W C Willett; L Sampson; M J Stampfer; B Rosner; C Bain; J Witschi; C H Hennekens; F E Speizer
Journal:  Am J Epidemiol       Date:  1985-07       Impact factor: 4.897

7.  Glucose-induced inhibition of in vitro bone mineralization.

Authors:  E Balint; P Szabo; C F Marshall; S M Sprague
Journal:  Bone       Date:  2001-01       Impact factor: 4.398

8.  Bone mass and structure in adolescents with type 1 diabetes compared to healthy peers.

Authors:  M T Saha; H Sievänen; M K Salo; S Tulokas; H H Saha
Journal:  Osteoporos Int       Date:  2008-12-13       Impact factor: 4.507

9.  Role of nonenzymatic glycosylation of type I collagen in diabetic osteopenia.

Authors:  Y Katayama; T Akatsu; M Yamamoto; N Kugai; N Nagata
Journal:  J Bone Miner Res       Date:  1996-07       Impact factor: 6.741

10.  A study of bone mineral density and its determinants in type 1 diabetes mellitus.

Authors:  Ameya Joshi; Premlata Varthakavi; Manoj Chadha; Nikhil Bhagwat
Journal:  J Osteoporos       Date:  2013-03-31
View more
  5 in total

Review 1.  The effects of weight loss approaches on bone mineral density in adults: a systematic review and meta-analysis of randomized controlled trials.

Authors:  S Soltani; G R Hunter; A Kazemi; S Shab-Bidar
Journal:  Osteoporos Int       Date:  2016-05-06       Impact factor: 4.507

Review 2.  An update on the potential role of C-peptide in diabetes and osteoporosis.

Authors:  Arturo Pujia; Carmine Gazzaruso; Tiziana Montalcini
Journal:  Endocrine       Date:  2017-04-03       Impact factor: 3.633

3.  Free and Bioavailable Vitamin D Levels of Patients with Type 1 Diabetes Mellitus and Association with Bone Metabolism.

Authors:  Ceyda Dincer Yazan; Ali Yaman; Goncagul Haklar; Onder Sirikci; Oguzhan Deyneli
Journal:  J Diabetes Metab Disord       Date:  2022-04-05

Review 4.  Osteoporosis: Modern Paradigms for Last Century's Bones.

Authors:  Marlena C Kruger; Frances M Wolber
Journal:  Nutrients       Date:  2016-06-17       Impact factor: 5.717

5.  Lower bone mineral density and higher bone resorption marker levels in premenopausal women with type 1 diabetes in Japan.

Authors:  Fumi Yoshioka; Shinsuke Nirengi; Takashi Murata; Yaeko Kawaguchi; Tomokazu Watanabe; Kunio Saeki; Muneto Yoshioka; Naoki Sakane
Journal:  J Diabetes Investig       Date:  2021-04-03       Impact factor: 4.232

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.